Chemomab Therapeutics Ltd DRC (CMMB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.31M
Last updated: Nov 17, 2026 at 4:04 PM ET
Chemomab Therapeutics Ltd DRC (CMMB) Stock Chart
Chemomab Therapeutics Ltd DRC (CMMB) has a latest price of $1.64 on Nov 17, 2026, 45.2% below its 52-week high of $2.99. Its price fell 38.3% over the past 12 months. The month-end price fell 97.1% over the 5 years through Oct 2026, a compound annual decline of 50.8%.
Price Chart
From Feb 2019 to Oct 2026, its highest month-end close was $512.00 in Feb 2019 and its lowest $1.16 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CMMB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CMMB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 21.5%, and over 6 months it rose 5.8%. The month-end price fell 60.4% over the 3 years through Oct 2026, a compound annual decline of 26.6%.
| Period | Change |
|---|---|
| 1 month | +40.2% |
| 3 months | -21.5% |
| 6 months | +5.8% |
| 12 months | -38.3% |
| 12 months, with dividends | -38.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -60.4% | -26.6% |
| 5 years | -97.1% | -50.8% |
Price by Year
Its best calendar year was 2024, when the price rose 254.9%, and its weakest was 2023, when it fell 84.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.16 | -29.7% |
| 2025 | $1.65 | -77.2% |
| 2024 | $7.24 | +254.9% |
| 2023 | $2.04 | -84.1% |
| 2022 | $12.80 | -53.6% |
| 2021 | $27.60 | -75.1% |
| 2020 | $110.72 | +23.6% |
Trading Range
The price is 2.1% above its 50-day average of $1.61 and 5.5% below its 200-day average of $1.74.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.64 | |
| 52-week high | $2.99 | -45.2% |
| 52-week low | $0.92 | +78.3% |
| 50-day average | $1.61 | +2.1% |
| 200-day average | $1.74 | -5.5% |
Price Risk
Over 3 years, its largest fall from a peak was 89.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.35 |
| Largest fall, 1 year | -64.7% |
| Largest fall, 3 years | -89.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CMMB
What is CMMB's 1-year price change?
Chemomab Therapeutics Ltd DRC's price fell 38.3% over the past 12 months. With dividends included, the 12-month total return was -38.3%.
What is CMMB's 5-year price change?
Chemomab Therapeutics Ltd DRC's month-end price fell 97.1% over the 5 years through Oct 2026, a compound annual decline of 50.8%. These figures leave out dividends.
What is CMMB's 52-week high and low?
Chemomab Therapeutics Ltd DRC's 52-week high is $2.99 and its 52-week low is $0.92. Its latest price of $1.64 on Nov 17, 2026 is 45.2% below the high.
What is CMMB's beta?
Chemomab Therapeutics Ltd DRC's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 64.7%.
Is the CMMB chart free?
Yes. Advanced Charting for CMMB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CMMB pages: Overview, Charting, Earnings, Forecast, Statistics, Competitors